By Julie Donnelly
Invo Bioscience has a very special announcement to make — it is the proud parent of a fertility device that has produced its first baby.
The Beverly-based medical device firm’s Invocell device was launched in the Middle East early this year, and a healthy baby arrived on September 29 to a Pakistani mother. The mother, who is 40, was trying to get pregnant for 16 years.
The procedure involves combining sperm and eggs in a device that is implanted in the woman for three days to incubate. Then one or two resulting embryos are transferred to the uterus so it can implant and the pregnancy can continue.
The announcement is sweet because in the life sciences, tangible results are few and far between. Creating a drug, for instance, takes at least ten years and up to $1 billion. For medical devices, the FDA approval process is somewhat quicker and easier. But researchers and company executives alike still must possess tremendous patience and stamina getting life science products to market. There are many more failures than successes. And success is often measured in little increments, such as extending the life of a cancer patient for a few weeks.
But you can’t be a little pregnant. A woman in Pakistan can now happily attest to that.
Kudos, Invo Bioscience.
RSS Feeds
